167 related articles for article (PubMed ID: 23180015)
1. MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy.
de Carvalho F; Alves VL; Braga WM; Xavier CV; Colleoni GW
Cancer Immunol Immunother; 2013 Jan; 62(1):191-5. PubMed ID: 23180015
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.
Pabst C; Zustin J; Jacobsen F; Luetkens T; Kröger N; Schilling G; Bokemeyer C; Sauter G; Atanackovic D; Marx A
Exp Mol Pathol; 2010 Oct; 89(2):175-81. PubMed ID: 20621094
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.
Atanackovic D; Luetkens T; Hildebrandt Y; Arfsten J; Bartels K; Horn C; Stahl T; Cao Y; Zander AR; Bokemeyer C; Kröger N
Clin Cancer Res; 2009 Feb; 15(4):1343-52. PubMed ID: 19190130
[TBL] [Abstract][Full Text] [Related]
4. Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.
Curioni-Fontecedro A; Nuber N; Mihic-Probst D; Seifert B; Soldini D; Dummer R; Knuth A; van den Broek M; Moch H
PLoS One; 2011; 6(6):e21418. PubMed ID: 21738656
[TBL] [Abstract][Full Text] [Related]
5. Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
Dhodapkar MV; Osman K; Teruya-Feldstein J; Filippa D; Hedvat CV; Iversen K; Kolb D; Geller MD; Hassoun H; Kewalramani T; Comenzo RL; Coplan K; Chen YT; Jungbluth AA
Cancer Immun; 2003 Jul; 3():9. PubMed ID: 12875607
[TBL] [Abstract][Full Text] [Related]
6. Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients.
Inaoka RJ; Jungbluth AA; Gnjatic S; Ritter E; Hanson NC; Frosina D; Tassello J; Etto LY; Bortoluzzo AB; Alves AC; Colleoni GW
Cancer Immunol Immunother; 2012 Dec; 61(12):2207-14. PubMed ID: 22638551
[TBL] [Abstract][Full Text] [Related]
7. The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation.
Jungbluth AA; Ely S; DiLiberto M; Niesvizky R; Williamson B; Frosina D; Chen YT; Bhardwaj N; Chen-Kiang S; Old LJ; Cho HJ
Blood; 2005 Jul; 106(1):167-74. PubMed ID: 15761016
[TBL] [Abstract][Full Text] [Related]
8. Expression of cancer testis antigens CT10 (MAGE-C2) and GAGE in gastrointestinal stromal tumors.
Ghadban T; Perez DR; Vashist YK; Bockhorn M; Koenig AM; El Gammal AT; Izbicki JR; Metzger U; Hauswirth F; Frosina D; Jungbluth AA
Eur J Surg Oncol; 2014 Oct; 40(10):1307-12. PubMed ID: 24713551
[TBL] [Abstract][Full Text] [Related]
9. CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis.
Güre AO; Stockert E; Arden KC; Boyer AD; Viars CS; Scanlan MJ; Old LJ; Chen YT
Int J Cancer; 2000 Mar; 85(5):726-32. PubMed ID: 10699956
[TBL] [Abstract][Full Text] [Related]
10. MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome.
Tinguely M; Jenni B; Knights A; Lopes B; Korol D; Rousson V; Curioni Fontecedro A; Cogliatti SB; Bittermann AG; Schmid U; Dommann-Scherrer C; Maurer R; Renner C; Probst-Hensch NM; Moch H; Knuth A; Zippelius A
Cancer Sci; 2008 Apr; 99(4):720-5. PubMed ID: 18307538
[TBL] [Abstract][Full Text] [Related]
11. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ
Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159
[TBL] [Abstract][Full Text] [Related]
12. Expression of cancer-testis antigen in multiple myeloma.
He L; Ji JN; Liu SQ; Xue E; Liang Q; Ma Z
J Huazhong Univ Sci Technolog Med Sci; 2014 Apr; 34(2):181-185. PubMed ID: 24710929
[TBL] [Abstract][Full Text] [Related]
13. Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines.
de Carvalho F; Costa ET; Camargo AA; Gregorio JC; Masotti C; Andrade VC; Strauss BE; Caballero OL; Atanackovic D; Colleoni GW
PLoS One; 2011; 6(11):e27707. PubMed ID: 22110734
[TBL] [Abstract][Full Text] [Related]
14. The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma.
Zhang Y; Bao L; Lu J; Liu KY; Li JL; Qin YZ; Chen H; Li LD; Kong Y; Shi HX; Lai YY; Liu YR; Jiang B; Chen SS; Huang XJ; Ruan GR
Mol Cancer; 2014 Feb; 13():25. PubMed ID: 24499297
[TBL] [Abstract][Full Text] [Related]
15. High expression of cancer testis antigens MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, and gage in advanced squamous cell carcinoma of the larynx.
Figueiredo DL; Mamede RC; Spagnoli GC; Silva WA; Zago M; Neder L; Jungbluth AA; Saggioro FP
Head Neck; 2011 May; 33(5):702-7. PubMed ID: 20886663
[TBL] [Abstract][Full Text] [Related]
16. [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery].
Wang Y; Liang Z; Yuan YH; Han Y; Liu YX; Liu N; Chen YT; Ritter G; Old LJ; Zhang LJ
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):464-8. PubMed ID: 15061963
[TBL] [Abstract][Full Text] [Related]
17. [The expression of 11 cancer/testis (CT) antigen genes in esophageal carcinoma].
Liang Z; Sun ZY; Yuan YH; Han Y; Wang Y; Gu J; Zhang LJ
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):534-7. PubMed ID: 16438850
[TBL] [Abstract][Full Text] [Related]
18. Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas.
Zimmermann AK; Imig J; Klar A; Renner C; Korol D; Fink D; Stadlmann S; Singer G; Knuth A; Moch H; Caduff R
Virchows Arch; 2013 May; 462(5):565-74. PubMed ID: 23529156
[TBL] [Abstract][Full Text] [Related]
19. Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2.
Zhuang R; Zhu Y; Fang L; Liu XS; Tian Y; Chen LH; Ouyang WM; Xu XG; Jian JL; Güre AO; Fortunato S; Ritter G; Old LJ; Simpson AJ; Chen YT; Jin B; Jungbluth AA
Cancer Immun; 2006 Apr; 6():7. PubMed ID: 16594646
[TBL] [Abstract][Full Text] [Related]
20. MAGE genes: Prognostic indicators in AL amyloidosis patients.
Liu Y; Wen L; Ma L; Kang Y; Liu KY; Huang XJ; Ruan GR; Lu J
J Cell Mol Med; 2019 Aug; 23(8):5672-5678. PubMed ID: 31222935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
